Published • loading... • Updated
Amgen to invest $600M in new US center; Sanofi drug for ITP approved
Amgen's $600 million investment aims to enhance advanced automation and digital innovation for serious disease therapies, supported by recent U.S. corporate tax cuts.
Summary by biopharmadive.com
3 Articles
3 Articles
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium